Subsequently, ChIP assays of accordingly treated MCC cells revealed that the addition of mithramycin A boosted vorinostat induced histone acetylation resulting in an acetylation of ~66% of histones at the MICA promoter and almost complete histone acetylation at the MICB promoter. Here, MICA is linked to Merkel cell skin cancer.